| Active Pharmaceutical Ingredients Development |
| 1. | The development of Cephalospornic antibiotics and intermediaries; especially, Cephalexin has been certified by the U.S.FDA in 1994. |
| 2. | R&D leading high-end drug stocks focusing on treatment arthritis, osteoporosis, BPH, and cardiovascular diseases. |
| 3. | Developing ingredients and intermediaries by ferment method |
| Pharmaceutical Finished & Biotech Related Products Development: |
| 1. | Chinese herbal Product R&D
Researching and developing methods including extraction, purification, and formula development help bring natural substances and Chinese herbal into the domain of health food and drugs |
| 2. | Controlled release drugs
A controlled release drugs have been developed to excel the quality of drug dispensing. |
| 3. | Sterile formulation development
Backed by professional know-how and the unique processing equipment are adopted for leading sterile formulas research, produced by the automated PE Blowing-filling-sealing. |
| 4. | Dialysis treatment drugs
Developing most comprehensive dialysis drugs of in ensemble for the local market. |
| 5. | Contact lens solution and ophthalmic drugs
The unit dose package formula to improve the usage quality and easy to use. |
| 6. | Oral hygiene products
The supplying of school children to prevent dental caries used in mouthwash and related products |
| 7. | BE drug development
78 products have till 2005 been BE tested and certified. |
| Technical collaboration pact: |
| A technical collaboration pact working with the U.S. pharmaceutical development firm, Medinox, has yield a series of nitro oxide based and internal disease inhibiting drugs, designed to combat septic shocks, adult respiratory arrest, diabetes, and so forth. |
